Implementation of 2% Chlorhexidine Bathing to Reduce Healthcare-Associated Infections Among Patients in the Intensive Care Unit
- PMID: 39858834
- PMCID: PMC11767414
- DOI: 10.3390/microorganisms13010065
Implementation of 2% Chlorhexidine Bathing to Reduce Healthcare-Associated Infections Among Patients in the Intensive Care Unit
Abstract
Healthcare-associated infections (HAIs) significantly increase morbidity, mortality, length of hospital stays, and costs, particularly among ICU patients. Despite standard interventions, catheter-associated urinary tract infections (CAUTI) and central line-associated bloodstream infections (CLABSI) remain major HAI contributors. This study evaluated the efficacy of daily 2% chlorhexidine gluconate (CHG) bathing in reducing HAI incidence, specifically CAUTI, CLABSI, and multidrug-resistant organisms (MDROs), in a 20-bed ICU at a regional hospital. Using a prospective, uncontrolled before-and-after design, we compared traditional soap-water bathing (pre-intervention period) with CHG bathing over a one-year intervention and one-year post-intervention follow-up. The total number of patients and patient days admitted to the ICU per year were around 1330-1412 patients and 6702-6927 patient days, respectively, during 2018-2020. Results showed a significant reduction in HAI incidence rates from 3.43‱ to 0.58‱ (p < 0.05) during the intervention and sustained benefits post-intervention. Incidences of CAUTI and CLABSI decreased markedly (p < 0.05), with reduced MDRO isolates, including methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococci, carbapenem-resistant Acinetobacter baumannii, and Pseudomonas aeruginosa. Our findings support the implementation of daily CHG bathing as an effective strategy to reduce HAI and MDROs in ICU settings.
Keywords: catheter-associated bloodstream infections; catheter-associated urinary tract infections; chlorhexidine gluconate; healthcare-associated infections; multidrug-resistant organisms.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
References
-
- Taiwan Centers for Diseases Control Annual Report of Nosocomial Infections Surveillance System. [(accessed on 24 April 2024)];2019 Available online: https://www.cdc.gov.tw/En/Category/Page/J63NmsvevBg2u3I2qYBenw.
-
- Huang S.S., Septimus E., Hayden M.K., Kleinman K., Sturtevant J., Avery T.R., Moody J., Hickok J., Lankiewicz J., Gombosev A., et al. Effect of body surface decolonisation on bacteriuria and candiduria in intensive care units: An analysis of a cluster-randomised trial. Lancet Infect. Dis. 2016;16:70–79. doi: 10.1016/S1473-3099(15)00238-8. - DOI - PubMed
-
- Van den Poel B., Saegeman V., Schuermans A. Increasing usage of chlorhexidine in health care settings: Blessing or curse? A narrative review of the risk of chlorhexidine resistance and the implications for infection prevention and control. Eur. J. Clin. Microbiol. Infect. Dis. 2022;41:349–362. doi: 10.1007/s10096-022-04403-w. - DOI - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
